About this Journal Submit a Manuscript Table of Contents
Gastroenterology Research and Practice
Volume 2010 (2010), Article ID 212563, 11 pages
http://dx.doi.org/10.1155/2010/212563
Review Article

TLR4 and Insulin Resistance

1Department of Pediatrics, University of California, San Diego, CA 92093-0673, USA
2Rady Children's Hospital, San Diego, CA 92093-0673, USA
3Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0673, USA

Received 21 April 2010; Accepted 24 June 2010

Academic Editor: Ekihiro Seki

Copyright © 2010 Jane J. Kim and Dorothy D. Sears. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. de Luca and J. M. Olefsky, “Inflammation and insulin resistance,” FEBS Letters, vol. 582, no. 1, pp. 97–105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. M. Grundy, H. B. Brewer Jr., J. I. Cleeman, S. C. Smith Jr., and C. Lenfant, “Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition,” Circulation, vol. 109, no. 3, pp. 433–438, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Olefsky and C. K. Glass, “Macrophages, inflammation, and insulin resistance,” Annual Review of Physiology, vol. 72, pp. 219–246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. P. K. Shah, “Innate immune pathway links obesity to insulin resistance,” Circulation Research, vol. 100, no. 11, pp. 1531–1533, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. G. S. Hotamisligil and E. Erbay, “Nutrient sensing and inflammation in metabolic diseases,” Nature Reviews Immunology, vol. 8, no. 12, pp. 923–934, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Schenk, M. Saberi, and J. M. Olefsky, “Insulin sensitivity: modulation by nutrients and inflammation,” Journal of Clinical Investigation, vol. 118, no. 9, pp. 2992–3002, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Ehrchen, C. Sunderkötter, D. Foell, T. Vogl, and J. Roth, “The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer,” Journal of Leukocyte Biology, vol. 86, no. 3, pp. 557–566, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. E. Bianchi, “HMGB1 loves company,” Journal of Leukocyte Biology, vol. 86, no. 3, pp. 573–576, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. P. Gondokaryono, H. Ushio, F. Niyonsaba et al., “The extra domain A of fibronectin stimulates murine mast cells via Toll-like receptor 4,” Journal of Leukocyte Biology, vol. 82, no. 3, pp. 657–665, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. I. Miller, et al., “Toll-like receptor-4 and lipoprotein accumulation in macrophages,” Trends in Cardiovascular Medicine, vol. 19, no. 7, pp. 227–232, 2009.
  11. P. Mandal, P.-H. Park, M. R. McMullen, B. T. Pratt, and L. E. Nagy, “The anti-inflammatory effects of adiponectin are mediated via a heme oxygenase-1-dependent pathway in rat kupffer cells,” Hepatology, vol. 51, no. 4, pp. 1420–1429, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Huang, P.-H. Park, M. R. McMullen, and L. E. Nagy, “Mechanisms for the anti-inflammatory effects of adiponectin in macrophages,” Journal of Gastroenterology and Hepatology, vol. 23, supplement 1, pp. S50–S53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Kamio, S. Akifusa, N. Yamaguchi, K. Nonaka, and Y. Yamashita, “Anti-inflammatory activity of a globular adiponectin function on RAW 264 cells stimulated by lipopolysaccharide from Aggregatibacter actinomycetemcomitans,” FEMS Immunology and Medical Microbiology, vol. 56, no. 3, pp. 241–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Neumeier, J. Weigert, A. Schäffler et al., “Different effects of adiponectin isoforms in human monocytic cells,” Journal of Leukocyte Biology, vol. 79, no. 4, pp. 803–808, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Yamaguchi, J. G. M. Argueta, Y. Masuhiro et al., “Adiponectin inhibits Toll-like receptor family-induced signaling,” FEBS Letters, vol. 579, no. 30, pp. 6821–6826, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Sag, D. Carling, R. D. Stout, and J. Suttles, “Adenosine 5'-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype,” Journal of Immunology, vol. 181, no. 12, pp. 8633–8641, 2008. View at Scopus
  17. C. K. Glass and S. Ogawa, “Combinatorial roles of nuclear receptors in inflammation and immunity,” Nature Reviews Immunology, vol. 6, no. 1, pp. 44–55, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. R. Dasu, S. Park, S. Devaraj, and I. Jialal, “Pioglitazone inhibits toll-like receptor expression and activity in human monocytes and db/db mice,” Endocrinology, vol. 150, no. 8, pp. 3457–3464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. M. Reynolds, E. Draper, B. Keogh et al., “A conjugated linoleic acid-enriched beef diet attenuates lipopolysaccharide-induced inflammation in mice in part through PPARγ-mediated suppression of toll-like receptor 4,” Journal of Nutrition, vol. 139, no. 12, pp. 2351–2357, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. B. M. Necela, W. Su, and E. A. Thompson, “Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor γ and nuclear factor-κB in macrophages,” Immunology, vol. 125, no. 3, pp. 344–358, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. L. A. Jones, J.-P. Anthony, F. L. Henriquez et al., “Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors,” Immunology, vol. 125, no. 1, pp. 59–69, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Miller, E. W. Alley, W. J. Murphy, S. W. Russell, and J. S. Hunt, “Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages,” Journal of Leukocyte Biology, vol. 59, no. 3, pp. 442–450, 1996. View at Scopus
  23. J. A. Rettew, Y. M. Huet, and I. Marriott, “Estrogens augment cell surface TLR4 expression on murine macrophages and regulate sepsis susceptibility in vivo,” Endocrinology, vol. 150, no. 8, pp. 3877–3884, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. A. Rettew, Y. M. Huet-Hudson, and I. Marriott, “Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity,” Biology of Reproduction, vol. 78, no. 3, pp. 432–437, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Y. Lee, K. H. Sohn, S. H. Rhee, and D. Hwang, “Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4,” Journal of Biological Chemistry, vol. 276, no. 20, pp. 16683–16689, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier, “TLR4 links innate immunity and fatty acid-induced insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 11, pp. 3015–3025, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Y. Lee, A. Plakidas, W. H. Lee et al., “Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids,” Journal of Lipid Research, vol. 44, no. 3, pp. 479–486, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. S. W. Wong, M.-J. Kwon, A. M. K. Choi, H.-P. Kim, K. Nakahira, and D. H. Hwang, “Fatty acids modulate toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner,” Journal of Biological Chemistry, vol. 284, no. 40, pp. 27384–27392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Brown, S. Chung, J. K. Sawyer et al., “Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis,” Circulation, vol. 118, no. 14, pp. 1467–1475, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. M. L. E. MacDonald, M. Van Eck, R. B. Hildebrand et al., “Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 3, pp. 341–347, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. J. M. Brown, S. Chung, J. K. Sawyer et al., “Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 1, pp. 24–30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. R. S. Chapkin, N. Wang, Y.-Y. Fan, J. R. Lupton, and I. A. Prior, “Docosahexaenoic acid alters the size and distribution of cell surface microdomains,” Biochimica et Biophysica Acta, vol. 1778, no. 2, pp. 466–471, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. Q. Li, M. Wang, L. Tan et al., “Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts,” Journal of Lipid Research, vol. 46, no. 9, pp. 1904–1913, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. T. M. Stulnig, J. Huber, N. Leitinger et al., “Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition,” Journal of Biological Chemistry, vol. 276, no. 40, pp. 37335–37340, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. M. B. Fessler, L. L. Rudel, and J. M. Brown, “Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome,” Current Opinion in Lipidology, vol. 20, no. 5, pp. 379–385, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. B. S. Park, D. H. Song, H. M. Kim, B.-S. Choi, H. Lee, and J.-O. Lee, “The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex,” Nature, vol. 458, no. 7242, pp. 1191–1195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Erridge and N. J. Samani, “Saturated fatty acids do not directly stimulate toll-like receptor signaling,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 11, pp. 1944–1949, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Gao and M.-F. Tsan, “Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor α from murine macrophages,” Journal of Biological Chemistry, vol. 278, no. 25, pp. 22523–22529, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. K. E. Taylor, J. C. Giddings, and C. W. Van Den Berg, “C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 6, pp. 1225–1230, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Cohen, “The detection and interpretation of endotoxaemia,” Intensive Care Medicine, Supplement, vol. 26, supplement 1, pp. S51–S56, 2000. View at Scopus
  41. P. Brun, I. Castagliuolo, V. Di Leo et al., “Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis,” American Journal of Physiology, vol. 292, no. 2, pp. G518–G525, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. P. D. Cani and N. M. Delzenne, “The role of the gut microbiota in energy metabolism and metabolic disease,” Current Pharmaceutical Design, vol. 15, no. 13, pp. 1546–1558, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Erridge, T. Attina, C. M. Spickett, and D. J. Webb, “A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation,” American Journal of Clinical Nutrition, vol. 86, no. 5, pp. 1286–1292, 2007. View at Scopus
  44. A. Spruss, G. Kanuri, S. Wagnerberger, S. Haub, S. C. Bischoff, and I. Bergheim, “Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice,” Hepatology, vol. 50, no. 4, pp. 1094–1104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Ghoshal, J. Witta, J. Zhong, W. de Villiers, and E. Eckhardt, “Chylomicrons promote intestinal absorption of lipopolysaccharides,” Journal of Lipid Research, vol. 50, no. 1, pp. 90–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. M. D. Neal, C. Leaphart, R. Levy et al., “Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier,” Journal of Immunology, vol. 176, no. 5, pp. 3070–3079, 2006. View at Scopus
  47. S. J. Creely, P. G. McTernan, C. M. Kusminski et al., “Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes,” American Journal of Physiology, vol. 292, no. 3, pp. E740–E747, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. M. R. Dasu, S. Devaraj, S. Park, and I. Jialal, “Increased Toll-Like Receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects,” Diabetes Care, vol. 33, no. 4, pp. 861–868, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. P. D. Cani, J. Amar, M. A. Iglesias et al., “Metabolic endotoxemia initiates obesity and insulin resistance,” Diabetes, vol. 56, no. 7, pp. 1761–1772, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Bäckhed, J. K. Manchester, C. F. Semenkovich, and J. I. Gordon, “Mechanisms underlying the resistance to diet-induced obesity in germ-free mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 3, pp. 979–984, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. P. D. Cani, R. Bibiloni, C. Knauf et al., “Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice,” Diabetes, vol. 57, no. 6, pp. 1470–1481, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Membrez, F. Blancher, M. Jaquet et al., “Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice,” FASEB Journal, vol. 22, no. 7, pp. 2416–2426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. F. Kim, M. Pham, I. Luttrell et al., “Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity,” Circulation Research, vol. 100, no. 11, pp. 1589–1596, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Saberi, N.-B. Woods, C. de Luca et al., “Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice,” Cell Metabolism, vol. 10, no. 5, pp. 419–429, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. J. E. Davis, N. K. Gabler, J. Walker-Daniels, and M. E. Spurlock, “Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat,” Obesity, vol. 16, no. 6, pp. 1248–1255, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. K. R. Coenen, M. L. Gruen, R. S. Lee-Young, M. J. Puglisi, D. H. Wasserman, and A. H. Hasty, “Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice,” Diabetologia, vol. 52, no. 2, pp. 318–328, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. K. S. Michelsen, M. H. Wong, P. K. Shah et al., “Lack of toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 29, pp. 10679–10684, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Björkbacka, V. V. Kunjathoor, K. J. Moore et al., “Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways,” Nature Medicine, vol. 10, no. 4, pp. 416–421, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Roncon-Albuquerque Jr., M. Moreira-Rodrigues, B. Faria et al., “Attenuation of the cardiovascular and metabolic complications of obesity in CD14 knockout mice,” Life Sciences, vol. 83, no. 13-14, pp. 502–510, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. R. A. Bagarolli, M. J. A. Saad, and S. T. O. Saad, “Toll-like receptor 4 and inducible nitric oxide synthase gene polymorphisms are associated with type 2 diabetes,” Journal of Diabetes and Its Complications, vol. 24, no. 3, pp. 192–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Ferwerda, M. B. B. McCall, K. Verheijen et al., “Functional consequences of toll-like receptor 4 polymorphisms,” Molecular Medicine, vol. 14, no. 5-6, pp. 346–352, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. A. P. Steinhardt, F. Aranguren, M. L. Tellechea et al., “A functional nonsynonymous toll-like receptor 4 gene polymorphism is associated with metabolic syndrome, surrogates of insulin resistance, and syndromes of lipid accumulation,” Metabolism, vol. 59, no. 5, pp. 711–717, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. R. Coppari, M. Ichinose, C. E. Lee et al., “The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity,” Cell Metabolism, vol. 1, no. 1, pp. 63–72, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Pocai, K. Morgan, C. Buettner, R. Gutierrez-Juarez, S. Obici, and L. Rossetti, “Central leptin acutely reverses diet-induced hepatic insulin resistance,” Diabetes, vol. 54, no. 11, pp. 3182–3189, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Galic, J. S. Oakhill, and G. R. Steinberg, “Adipose tissue as an endocrine organ,” Molecular and Cellular Endocrinology, vol. 316, no. 2, pp. 129–139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr., “Obesity is associated with macrophage accumulation in adipose tissue,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796–1808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. H. Xu, G. T. Barnes, Q. Yang et al., “Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1821–1830, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. P. J. Bilan, V. Samokhvalov, A. Koshkina, J. D. Schertzer, M. C. Samaan, and A. Klip, “Direct and macrophage-mediated actions of fatty acids causing insulin resistance in muscle cells,” Archives of Physiology and Biochemistry, vol. 115, no. 4, pp. 176–190, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. D. Patsouris, P.-P. Li, D. Thapar, J. Chapman, J. M. Olefsky, and J. G. Neels, “Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals,” Cell Metabolism, vol. 8, no. 4, pp. 301–309, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Cinti, G. Mitchell, G. Barbatelli et al., “Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans,” Journal of Lipid Research, vol. 46, no. 11, pp. 2347–2355, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Yuan, N. Konstantopoulos, J. Lee et al., “Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ,” Science, vol. 293, no. 5535, pp. 1673–1677, 2001. View at Publisher · View at Google Scholar · View at Scopus
  72. M. C. Arkan, A. L. Hevener, F. R. Greten et al., “IKK-β links inflammation to obesity-induced insulin resistance,” Nature Medicine, vol. 11, no. 2, pp. 191–198, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. G. Solinas, C. Vilcu, J. G. Neels et al., “JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity,” Cell Metabolism, vol. 6, no. 5, pp. 386–397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. J. K. Kim, J. J. Fillmore, M. J. Sunshine et al., “PKC-θ knockout mice are protected from fat-induced insulin resistance,” Journal of Clinical Investigation, vol. 114, no. 6, pp. 823–827, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. H.-M. Zhang, L.-L. Chen, L. Wang et al., “Macrophage infiltrates with high levels of Toll-like receptor 4 expression in white adipose tissues of male Chinese,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 10, pp. 736–743, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. M. T. A. Nguyen, S. Favelyukis, A.-K. Nguyen et al., “A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways,” Journal of Biological Chemistry, vol. 282, no. 48, pp. 35279–35292, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Bès-Houtmann, R. Roche, L. Hoareau et al., “Presence of functional TLR2 and TLR4 on human adipocytes,” Histochemistry and Cell Biology, vol. 127, no. 2, pp. 131–137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. M. J. Song, K. H. Kim, J. M. Yoon, and J. B. Kim, “Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes,” Biochemical and Biophysical Research Communications, vol. 346, no. 3, pp. 739–745, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. O. I. Vitseva, K. Tanriverdi, T. T. Tchkonia et al., “Inducible Toll-like receptor and NF-κB regulatory pathway expression in human adipose tissue,” Obesity, vol. 16, no. 5, pp. 932–937, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. K. Hoshino, O. Takeuchi, T. Kawai et al., “Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide evidence for TLR4 as the Lps gene product,” Journal of Immunology, vol. 162, no. 7, pp. 3749–3752, 1999. View at Scopus
  81. A. Poltorak, X. He, I. Smirnova et al., “Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene,” Science, vol. 282, no. 5396, pp. 2085–2088, 1998. View at Publisher · View at Google Scholar · View at Scopus
  82. C. R. H. Raetz, “Biochemistry of endotoxins,” Annual Review of Biochemistry, vol. 59, pp. 129–170, 1990. View at Scopus
  83. Y. Lin, H. Lee, A. H. Berg, M. P. Lisanti, L. Shapiro, and P. E. Scherer, “The lipopolysaccharide-activated Toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes,” Journal of Biological Chemistry, vol. 275, no. 32, pp. 24255–24263, 2000. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Y. Lee and D. H. Hwang, “The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors,” Molecules and Cells, vol. 21, no. 2, pp. 174–185, 2006. View at Scopus
  85. L. H. Storlien, E. W. Kraegen, and D. J. Chisholm, “Fish oil prevents insulin resistance induced by high-fat feeding in rats,” Science, vol. 237, no. 4817, pp. 885–888, 1987. View at Scopus
  86. T. Suganami, T. Mieda, M. Itoh, Y. Shimoda, Y. Kamei, and Y. Ogawa, “Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation,” Biochemical and Biophysical Research Communications, vol. 354, no. 1, pp. 45–49, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. D. M. L. Tsukumo, M. A. Carvalho-Filho, J. B. C. Carvalheira et al., “Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance,” Diabetes, vol. 56, no. 8, pp. 1986–1998, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Poggi, D. Bastelica, P. Gual et al., “C3H/HeJ mice carrying a Toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet,” Diabetologia, vol. 50, no. 6, pp. 1267–1276, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. T. Suganami, K. Tanimoto-Koyama, J. Nishida et al., “Role of the Toll-like receptor 4/NF-κB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 1, pp. 84–91, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. V. D. F. De Mello, M. Kolehmainen, L. Pulkkinen et al., “Downregulation of genes involved in NFκB activation in peripheral blood mononuclear cells after weight loss is associated with the improvement of insulin sensitivity in individuals with the metabolic syndrome: the GENOBIN study,” Diabetologia, vol. 51, no. 11, pp. 2060–2067, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. L. Bouwens, M. Baekeland, R. De Zanger, and E. Wisse, “Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver,” Hepatology, vol. 6, no. 4, pp. 718–722, 1986. View at Scopus
  92. K. Miura, et al., “Role of Toll-like receptors and their downstream molecules in the development of non-alcoholic fatty liver disease,” Gastroenterology Research and Practice. In press.
  93. G. Baffy, “Kupffer cells in non-alcoholic fatty liver disease: the emerging view,” Journal of Hepatology, vol. 51, no. 1, pp. 212–223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. L. A. Videla, G. Tapia, R. Rodrigo et al., “Liver NF-κB and AP-1 DNA binding in obese patients,” Obesity, vol. 17, no. 5, pp. 973–979, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. C. F. Raetzsch, N. L. Brooks, J. M. Alderman et al., “Lipopolysaccharide inhibition of glucose production through the Toll-like receptor-4, myeloid differentiation factor 88, and nuclear factor κB pathway,” Hepatology, vol. 50, no. 2, pp. 592–600, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. R. A. DeFronzo, R. Gunnarsson, and O. Bjorkman, “Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus,” Journal of Clinical Investigation, vol. 76, no. 1, pp. 149–155, 1985. View at Scopus
  97. A. D. Baron, G. Brechtel, P. Wallace, and S. V. Edelman, “Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans,” American Journal of Physiology, vol. 255, no. 6, part 1, pp. E769–E774, 1988. View at Scopus
  98. O. G. Kolterman, J. Insel, M. Saekow, and J. M. Olefsky, “Mechanisms of insulin resistance in human obesity. Evidence for receptor and postreceptor defects,” Journal of Clinical Investigation, vol. 65, no. 6, pp. 1272–1284, 1980. View at Scopus
  99. G. S. Hotamisligil, P. Peraldi, A. Budavari, R. Ellis, M. F. White, and B. M. Spiegelman, “IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance,” Science, vol. 271, no. 5249, pp. 665–668, 1996. View at Scopus
  100. M. I. Frisard, R. P. McMillan, J. Marchand et al., “Toll-like receptor 4 modulates skeletal muscle substrate metabolism,” American Journal of Physiology, vol. 298, no. 5, pp. E988–E998, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. Y. Wei, K. Chen, A. T. Whaley-Connell, C. S. Stump, J. A. Ibdah, and J. R. Sowers, “Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species,” American Journal of Physiology, vol. 294, no. 3, pp. R673–R680, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. J. H. Boyd, M. Divangahi, L. Yahiaoui, D. Gvozdic, S. Qureshi, and B. J. Petrof, “Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-κB and calcineurin,” Infection and Immunity, vol. 74, no. 12, pp. 6829–6838, 2006. View at Publisher · View at Google Scholar · View at Scopus
  103. S. M. Reyna, S. Ghosh, P. Tantiwong et al., “Elevated Toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects,” Diabetes, vol. 57, no. 10, pp. 2595–2602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. J. J. Senn, “Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes,” Journal of Biological Chemistry, vol. 281, no. 37, pp. 26865–26875, 2006. View at Publisher · View at Google Scholar · View at Scopus
  105. D. A. Sandoval, S. Obici, and R. J. Seeley, “Targeting the CNS to treat type 2 diabetes,” Nature Reviews Drug Discovery, vol. 8, no. 5, pp. 386–398, 2009. View at Publisher · View at Google Scholar · View at Scopus
  106. S.-H. Chiang, M. Bazuine, C. N. Lumeng et al., “The protein kinase IKKε regulates energy balance in obese mice,” Cell, vol. 138, no. 5, pp. 961–975, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. C. T. De Souza, E. P. Araujo, S. Bordin et al., “Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus,” Endocrinology, vol. 146, no. 10, pp. 4192–4199, 2005. View at Publisher · View at Google Scholar · View at Scopus
  108. A. Kleinridders, D. Schenten, A. C. Könner et al., “MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity,” Cell Metabolism, vol. 10, no. 4, pp. 249–259, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. J. C. Moraes, A. Coope, J. Morari et al., “High-fat diet induces apoptosis of hypothalamic neurons,” PLoS ONE, vol. 4, no. 4, article e5045, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. L. Wen, J. Peng, Z. Li, and F. S. Wong, “The effect of innate immunity on autoimmune diabetes and the expression of Toll-like receptors on pancreatic islets,” Journal of Immunology, vol. 172, no. 5, pp. 3173–3180, 2004. View at Scopus
  111. A. Goldberg, M. Parolini, B. Y. Chin et al., “Toll-like receptor 4 suppression leads to islet allograft survival,” FASEB Journal, vol. 21, no. 11, pp. 2840–2848, 2007. View at Publisher · View at Google Scholar · View at Scopus
  112. H. S. Kim, M. S. Han, K. W. Chung et al., “Toll-like receptor 2 senses β-cell death and contributes to the initiation of autoimmune diabetes,” Immunity, vol. 27, no. 2, pp. 321–333, 2007. View at Publisher · View at Google Scholar · View at Scopus
  113. L. Wen, R. E. Ley, P. Y. Volchkov et al., “Innate immunity and intestinal microbiota in the development of type 1 diabetes,” Nature, vol. 455, no. 7216, pp. 1109–1113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. F. S. Wong, C. Hu, L. Zhang et al., “The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice,” Annals of the New York Academy of Sciences, vol. 1150, pp. 146–148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  115. F. T. Schulthess, F. Paroni, N. S. Sauter et al., “CXCL10 impairs β cell function and viability in diabetes through TLR4 signaling,” Cell Metabolism, vol. 9, no. 2, pp. 125–139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. M. Böni-Schnetzler, S. Boller, S. Debray et al., “Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I,” Endocrinology, vol. 150, no. 12, pp. 5218–5229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. X. Li, J. C. Tupper, D. D. Bannerman, R. K. Winn, C. J. Rhodes, and J. M. Harlan, “Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-κB in endothelial cells,” Infection and Immunity, vol. 71, no. 8, pp. 4414–4420, 2003. View at Publisher · View at Google Scholar · View at Scopus
  118. I. Marriott and Y. M. Huet-Hudson, “Sexual dimorphism in innate immune responses to infectious organisms,” Immunologic Research, vol. 34, no. 3, pp. 177–192, 2006. View at Publisher · View at Google Scholar · View at Scopus
  119. M.-P. Piccinni, E. Maggi, and S. Romagnani, “Role of hormone-controlled T-cell cytokines in the maintenance of pregnancy,” Biochemical Society Transactions, vol. 28, no. 2, pp. 212–215, 2000. View at Scopus
  120. R. Raghupathy, “Th1-type immunity is incompatible with successful pregnancy,” Immunology Today, vol. 18, no. 10, pp. 478–482, 1997. View at Publisher · View at Google Scholar · View at Scopus
  121. T. G. Wegmann, H. Lin, L. Guilbert, and T. R. Mosmann, “Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?” Immunology Today, vol. 14, no. 7, pp. 353–356, 1993. View at Scopus
  122. J. P. Frias, G. B. Macaraeg, J. Ofrecio, J. G. Yu, J. M. Olefsky, and Y. T. Kruszynska, “Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women,” Diabetes, vol. 50, no. 6, pp. 1344–1350, 2001. View at Scopus
  123. A. Hevener, D. Reichart, A. Janez, and J. Olefsky, “Female rats do not exhibit free fatty acid-induced insulin resistance,” Diabetes, vol. 51, no. 6, pp. 1907–1912, 2002. View at Scopus